# Prelude Therapeutics Inc: Form 8-K, filed Jan 9, 2026

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 07:30 ET
- Period: 2026-01-09
- Accession: 0001193125-26-008280
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/prld-20260109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/prld-20260109.htm

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-008280. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.